AU1779301A - Secretin and secretin pharmaceuticals for treating attention deficit disorder - Google Patents

Secretin and secretin pharmaceuticals for treating attention deficit disorder

Info

Publication number: AU1779301A
Authority: AU; Australia
Prior art keywords: secretin; pharmaceuticals; attention deficit; deficit disorder; treating attention
Prior art date: 1999-11-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU17793/01A

Inventor

Joseph A. Rogoff

F. Jack Warner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-22

Filing date

2000-11-17

Publication date

2001-06-04

2000-11-17 Application filed by Individual filed Critical Individual

2001-06-04 Publication of AU1779301A publication Critical patent/AU1779301A/en

Status Abandoned legal-status Critical Current

Links

102100037505 Secretin Human genes 0.000 title 2
108010086019 Secretin Proteins 0.000 title 2
229960002101 secretin Drugs 0.000 title 2
OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 title 2
208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 title 1
208000036864 Attention deficit/hyperactivity disease Diseases 0.000 title 1
208000015802 attention deficit-hyperactivity disease Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2235—Secretins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU17793/01A 1999-11-22 2000-11-17 Secretin and secretin pharmaceuticals for treating attention deficit disorder Abandoned AU1779301A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US16678499P	1999-11-22	1999-11-22
US60166784		1999-11-22
PCT/US2000/031786 WO2001037801A1 (en)	1999-11-22	2000-11-17	Secretin and secretin pharmaceuticals for treating attention deficit disorder

Publications (1)

Publication Number	Publication Date
AU1779301A true AU1779301A (en)	2001-06-04

Family

ID=22604692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU17793/01A Abandoned AU1779301A (en)	1999-11-22	2000-11-17	Secretin and secretin pharmaceuticals for treating attention deficit disorder

Country Status (2)

Country	Link
AU (1)	AU1779301A (en)
WO (1)	WO2001037801A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004100899A2 (en)	2003-05-13	2004-11-25	The Mclean Hospital Corporation	Use of secretin in treatments of disorders associated with the amygdala

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6197746B1 (en) *	1998-05-19	2001-03-06	Repligen Corporation	Method of using secretin for treating autism

2000
- 2000-11-17 AU AU17793/01A patent/AU1779301A/en not_active Abandoned
- 2000-11-17 WO PCT/US2000/031786 patent/WO2001037801A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2001037801A1 (en)	2001-05-31

Similar Documents

Publication	Publication Date	Title
AU2513400A (en)	2000-08-25	Authentication system and process
AU6222600A (en)	2001-02-05	System and methods for maintaining and distributing personal security devices
AU5165000A (en)	2000-12-12	Portable disinfection and filtration system
AU4225100A (en)	2000-11-14	Product authentication system and method
AU3860800A (en)	2000-10-04	Authentication system and methodology
GB2365185A8 (en)	2002-02-21	Systems and methods for trading
AU6629400A (en)	2001-03-19	Authentication system and method
AU1450601A (en)	2001-05-30	Transaction system and method therefor
AU5481900A (en)	2001-01-02	System and method for promising delivery of configured products with selected optimizations
AU6528800A (en)	2001-04-24	Methods and apparatuses for radiation treatment
AU4713601A (en)	2001-06-18	Method and system for treating stroke using hypothermia
AU4653999A (en)	2001-02-05	Exposure method and system
AU1332101A (en)	2001-04-23	Systems and methods for treating spinal pain
AU7617900A (en)	2001-04-30	System and method for controlling effluents in treatment systems
AU3195200A (en)	2000-10-09	Liquid treating method and liquid treating system
AU2938100A (en)	2000-09-28	Transdermal drug delivery system and method
ZA200203525B (en)	2003-07-18	Transdermal contraceptive delivery system and process.
AU2686800A (en)	2000-09-21	Security network and system
AU1539501A (en)	2001-06-25	Transaction system and method
AU7379900A (en)	2001-04-30	Units system and method
AU4060800A (en)	2000-10-23	Credit prequalification and granting system and method
AU5296500A (en)	2000-12-18	User support system and method
AU6357400A (en)	2001-02-13	System and methods for local intradermal treatment
AU1779301A (en)	2001-06-04	Secretin and secretin pharmaceuticals for treating attention deficit disorder
AU3641401A (en)	2001-05-14	Secretin and secretin pharmaceuticals for treating lactose intolerance

Legal Events

Date	Code	Title	Description
2002-08-01	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase